How Pandemic-Driven Talent Migration will Change Where Biotech Companies are Located

Just as Joel Marcus, JD, CPA, Executive Chairman and Founder of Alexandria Real Estate Equities, saw the rise of biotech and capitalized on it, he is reading the tea leaves as the pandemic fuels investor interest in biotech and upends business models. He talked about the future of the industry in Seattle and beyond in an interview with Life Science Washington CEO Leslie Alexandre, at the trade group’s annual summit last week.

“The war for talent is where it’s all at. If you’re starting a company, you’re not going to start in a place that doesn’t have a talent pool. You can’t build a company in a new city. You can put a small company together and you can grow it to a certain extent, but you can’t scale it in any meaningful fashion. I think the existing clusters are going to become even more dominant.”